Rohto Pharmaceutical Co.,Ltd. (4527.T) JPX

2,438.00

-23(-0.93%)

Updated at December 05 03:30PM

Currency In JPY

Valuation

Market Cap509.48B
Enterprise Value482.55B
P/E Ratio16.23
PEG Ratio1.48
Price/Sales Ratio1.7
Price/Book Ratio2.09
Enterprise/Revenue1.62
Enterprise/EBITDA10.01

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.11
Operating Margin0.12

Management Effectiveness

Return On Assets0.08
Return On Equity0.13

Income Statement

Revenue308.63B
Revenue/Share1,407.05
Gross Profit169.38B
EBITDA56.42B
Net Income31.01B
Diluted EPS135.46

Balance Sheet

Total Cash75.84B
Total Cash/Share331.16
Total Debt48.88B
Total Debt/Equity0.18
Current Ratio2.54
Book Value Per Share1,240.73

Price History

52-Week Change-15.63
52-Week High2,972.5
52-Week Low1,964.5
Moving Average 50 Days2,461.59
Moving Average 200 Days2,301.85

Statistics

Average Volume618,841
Shares Outstanding225.96M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate41
Trailing Annual Dividend Yield1.69
Payout Ratio0
Last Split Factor2:1
Last Split DateDecember 29, 2022